Filter News
Area of Research
- (-) Biology and Environment (8)
- (-) Materials (12)
- (-) Nuclear Science and Technology (18)
- Advanced Manufacturing (1)
- Clean Energy (10)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotopes (4)
- Materials for Computing (1)
- National Security (2)
- Neutron Science (6)
- Supercomputing (8)
News Type
News Topics
- (-) Advanced Reactors (5)
- (-) Biomedical (7)
- (-) Clean Water (1)
- (-) Composites (2)
- (-) Cybersecurity (1)
- (-) Isotopes (7)
- (-) Nuclear Energy (19)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (9)
- Artificial Intelligence (2)
- Big Data (2)
- Bioenergy (6)
- Biology (2)
- Biotechnology (1)
- Chemical Sciences (2)
- Climate Change (2)
- Computer Science (14)
- Coronavirus (8)
- Critical Materials (2)
- Decarbonization (1)
- Energy Storage (7)
- Environment (6)
- Exascale Computing (1)
- Fusion (7)
- Grid (1)
- High-Performance Computing (1)
- Machine Learning (3)
- Materials (2)
- Materials Science (27)
- Mathematics (1)
- Mercury (1)
- Microscopy (6)
- Molten Salt (2)
- Nanotechnology (16)
- National Security (1)
- Neutron Science (15)
- Physics (12)
- Polymers (4)
- Quantum Science (4)
- Security (1)
- Summit (5)
- Sustainable Energy (6)
- Transformational Challenge Reactor (4)
- Transportation (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...